There were no significant correlations between survivin and fibulin-3 serum levels within each group (P>0.05).Additionally, no significant correlations were found between biochemical markers and tumor stage among the patients with lung cancer and those with MPM (P>0.05). This evidence concerns the gene BIRC5 and lung cancer.